Institution
Beaumont Health
Nonprofit•Royal Oak, Michigan, United States•
About: Beaumont Health is a nonprofit organization based out in Royal Oak, Michigan, United States. It is known for research contribution in the topics: Medicine & Population. The organization has 1483 authors who have published 1448 publications receiving 15407 citations. The organization is also known as: William Beaumont Health System & Beaumont Hospitals.
Topics: Medicine, Population, Cancer, Breast cancer, Arthroplasty
Papers published on a yearly basis
Papers
More filters
••
University of Virginia1, Chia Nan University of Pharmacy and Science2, Taipei Veterans General Hospital3, National Yang-Ming University4, Banha University5, Ain Shams University6, Cairo University7, First Faculty of Medicine, Charles University in Prague8, University of Pittsburgh9, Beaumont Health10, Cleveland Clinic11, Penn State Milton S. Hershey Medical Center12
TL;DR: In patients with medically refractory prolact inomas or a residual/recurrent prolactinoma, SRS affords remarkable therapeutic effects in endocrine remission, endocrine control, and tumor control.
Abstract: Objective The most common functioning pituitary adenoma is prolactinoma. Patients with medically refractory or residual/recurrent tumors that are not amenable to resection can be treated with stereotactic radiosurgery (SRS). The aim of this multicenter study was to evaluate the role of SRS for treating prolactinomas. Methods This retrospective study included prolactinomas treated with SRS between 1997 and 2016 at ten institutions. Patients' clinical and treatment parameters were investigated. Patients were considered to be in endocrine remission when they had a normal level of prolactin (PRL) without requiring dopamine agonist medications. Endocrine control was defined as endocrine remission or a controlled PRL level ≤ 30 ng/ml with dopamine agonist therapy. Other outcomes were evaluated including new-onset hormone deficiency, tumor recurrence, and new neurological complications. Results The study cohort comprised 289 patients. The endocrine remission rates were 28%, 41%, and 54% at 3, 5, and 8 years after SRS, respectively. Following SRS, 25% of patients (72/289) had new hormone deficiency. Sixty-three percent of the patients (127/201) with available data attained endocrine control. Three percent of patients (9/269) had a new visual complication after SRS. Five percent of the patients (13/285) were recorded as having tumor progression. A pretreatment PRL level ≤ 270 ng/ml was a predictor of endocrine remission (p = 0.005, adjusted HR 0.487). An increasing margin dose resulted in better endocrine control after SRS (p = 0.033, adjusted OR 1.087). Conclusions In patients with medically refractory prolactinomas or a residual/recurrent prolactinoma, SRS affords remarkable therapeutic effects in endocrine remission, endocrine control, and tumor control. New-onset hypopituitarism is the most common adverse event.
11 citations
••
TL;DR: EPIC-μCT is sensitive to in vivo DDD induced by nucleotomy and provides a high resolution 3D method for mapping degenerative changes in rabbit IVDs.
11 citations
••
TL;DR: Results suggest that, when given a choice, verbal and video reinforcement are preferred over written reinforcement when receiving instructional reinforcement about self-care needed to prevent radiation dermatitis.
Abstract: Background Although patient preference is a core value within the context of patient-centered models of care, little attention has been paid to determining patient preference for instructional media. Nurses have traditionally used verbal face-to-face instruction as the mainstay of patient education, with written materials being used extensively as teaching guides to supplement verbal instruction or for instructional reinforcement. However, advances in technology have made possible the adding of video instruction to nurses' repertoire of instructional media. Objectives The purpose of this study was to determine patients' media preferences (verbal, video, written) when receiving instructional reinforcement about self-care needed to prevent radiation dermatitis. Methods The current study was conducted as a secondary analysis of data from a process improvement initiative. In the parent study, patients received multimedia education related to skin care to prevent radiation dermatitis. This secondary analysis examined patient preference for verbal, video, or written education reinforcement at treatment weeks 1 and 3. Findings Results suggest that, when given a choice, verbal and video reinforcement are preferred over written reinforcement.
10 citations
••
Beaumont Health1, University of Texas at Austin2, The Queen's Medical Center3, Indiana University4, University of Southern California5, Baylor College of Medicine6, Virginia Mason Medical Center7, University of California, San Francisco8, University of Florida9, Beth Israel Deaconess Medical Center10, University of Texas Health Science Center at Houston11, Mayo Clinic12, Dartmouth–Hitchcock Medical Center13, Johns Hopkins University14, Albert Einstein College of Medicine15, Anschutz Medical Campus16
TL;DR: The recommendations in this guideline were based on a systematic review of published literature, results from a nationwide survey of endoscopy directors, along with the expert guidance of the American Society for Gastrointestinal Endoscopy Standards of Practice Committee members and ASGE Practice Operation Committee members.
10 citations
••
TL;DR: In this article, the authors investigated the relationship between post-operative stereotactic radiosurgery (SRS) and leptomeningeal disease (LMD) in 7 tertiary care centers.
Abstract: Purpose Postoperative stereotactic radiosurgery (SRS) is associated with up to 30% risk of subsequent leptomeningeal disease (LMD). Radiographic patterns of LMD (classical sugarcoating [cLMD] vs. nodular [nLMD]) in this setting has been shown to be prognostic. However, the association of these findings with neurologic death (ND) is not well described. Methods and Materials The records for patients with brain metastases who underwent surgical resection and adjunctive SRS to 1 lesion (SRS to other intact lesions was allowed) and subsequently developed LMD were combined from 7 tertiary care centers. Salvage radiation therapy (RT) for LMD was categorized according to use of whole-brain versus focal cranial RT. Results The study cohort included 125 patients with known cause of death. The ND rate in these patients was 79%, and the rate in patients who underwent LMD salvage treatment (n = 107) was 76%. Univariate logistic regression demonstrated radiographic pattern of LMD (cLMD vs. nLMD, odds ratio: 2.9; P = .04) and second LMD failure after salvage treatment (odds ratio: 3.9; P = .02) as significantly associated with ND. The ND rate was 86% for cLMD versus 68% for nLMD. Whole-brain RT was used in 95% of patients with cLMD and 52% with nLMD. In the nLMD cohort (n = 58), there was no difference in ND rate based on type of salvage RT (whole-brain RT: 67% vs. focal cranial RT: 68%, P = .92). Conclusions LMD after surgery and SRS for brain metastases is a clinically significant event with high rates of ND. Classical LMD pattern (vs. nodular) and second LMD failure after salvage treatment were significantly associated with a higher risk of ND. Patients with nLMD treated with salvage focal cranial RT did not have higher ND rates compared with WBRT. Methods to decrease LMD and the subsequent high risk of ND in this setting warrant further investigation.
10 citations
Authors
Showing all 1494 results
Name | H-index | Papers | Citations |
---|---|---|---|
Barry P. Rosen | 102 | 529 | 36258 |
Praveen Kumar | 88 | 1339 | 35718 |
George S. Wilson | 88 | 716 | 33034 |
Ahmed Ali | 61 | 728 | 15197 |
Di Yan | 61 | 295 | 11437 |
David P. Wood | 59 | 243 | 12154 |
Brian D. Kavanagh | 58 | 322 | 15865 |
James A. Goldstein | 49 | 193 | 12312 |
Kenneth M. Peters | 46 | 197 | 6513 |
James M. Robbins | 45 | 157 | 8489 |
Bin Nan | 44 | 139 | 5321 |
Inga S. Grills | 43 | 217 | 6343 |
Sachin Kheterpal | 43 | 169 | 8545 |
Craig W. Stevens | 42 | 164 | 6598 |
Thomas Guerrero | 41 | 93 | 5018 |